Publications by authors named "A Delmonte"

Claim this Profile
C
Crizotinib in Patients With -Positive NSCLC With or Without Brain Metastases: Post Hoc Analysis of Phase II METROS Trial.
Lorenza Landi, Rita Chiari, Marcello Tiseo, Giulio Metro, Filippo de Marinis, Angelo Delmonte

JTO Clin Res Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Texture, Meltability, and Rheology of Faba Bean Protein/Kappa-Carrageenan Emulsion Gels: Impact of Protein Concentration, pH, Ionic Strength, and Storage.
Evangelina R Cappa, Agustina Delmonte, Osvaldo E Sponton, Liliana G Santiago, Adrián A Perez

J Texture Stud· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial.
Myung-Ju Ahn, Angelo Delmonte, Sharmistha Ghosh, Maximilian Hochmair, Tsung-Ying Yang

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study.
Rachel E Sanborn, Caicun Zhou, Ke-Jing Tang, Byoung Chul Cho, Susanna Cheng, Angelo Delmonte

Target Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study.
A R Filippi, M R García Campelo, J-B Paoli, D Kowalski, C Bennati, A Delmonte

ESMO Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis